Related Experiment Video
Updated: Jul 19, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
Published on: April 25, 2014
Spoligotype signatures in the Mycobacterium tuberculosis complex.
E M Streicher1, T C Victor, G van der Spuy
1DST/NRF Centre of Excellence in Biomedical TB Research, Department of Medical Biochemistry, Stellenbosch University, Tygerberg, South Africa 7505.
Mycobacterium tuberculosis direct repeat evolution created unique spoligotype signatures. These signatures help analyze strain populations and rapidly identify drug-resistant or immune-evading strains in trials.
Area of Science:
- Microbiology
- Genetics
- Epidemiology
Background:
- The direct repeat (DR) region in Mycobacterium tuberculosis (Mtb) evolves over time.
- This evolution leads to distinct spoligotype signatures.
- These signatures are linked to specific IS6110-defined Mtb strain families.
Purpose of the Study:
- To investigate the evolutionary patterns of the direct repeat region in Mtb.
- To establish the association between spoligotyping signatures and IS6110-defined strain families.
- To explore the utility of spoligotyping for analyzing Mtb population structure and identifying key clinical phenotypes.
Main Methods:
- Analysis of the direct repeat region evolution in Mtb.
- Spoligotyping to generate unique strain signatures.
- Correlation of spoligotype signatures with IS6110-based strain typing.
- Application in analyzing Mtb population dynamics and drug resistance patterns.
Main Results:
- Direct repeat evolution in Mtb generates characteristic spoligotype signatures.
- These signatures are specifically associated with IS6110-defined Mtb strain families.
- Spoligotyping provides a valuable tool for epidemiological studies.
Conclusions:
- Spoligotype signatures derived from direct repeat evolution are robust markers for Mtb strain families.
- Spoligotyping facilitates the analysis of Mtb population structure in diverse settings.
- This method enables rapid identification of strains with drug resistance or immune evasion properties, crucial for drug and vaccine development.
More Related Videos
08:48Separation and Fractionation of Culture Filtrate Proteins (CFPs) from Mycobacterium tuberculosis
Published on: July 11, 2025
07:42A Novel Microdissection Approach to Recovering Mycobacterium tuberculosis Specific Transcripts from Formalin Fixed Paraffin Embedded Lung Granulomas
Published on: June 5, 2014
Related Concept Videos
Modern Molecular Taxonomy
Tuberculosis
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Bacterial Phylum Actinobacteria
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...